Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)

Mise à jour : Il y a 4 ans
Référence : NCT02101957

Femme et Homme

  • | Pays :
  • France
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to evaluate the effect of cysteamine in patients with symptomatic Huntington's disease by comparing two groups of patients (cysteamine vs placebo) on the results of the Unified Huntington's Disease Rating Scale (UHDRS, Huntington study group 1996).


Critère d'inclusion

  • Huntington's disease

Liens